Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

Caitlin E. Cox

September 04, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2023

Shelley Wood

July 31, 2023

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Daily News

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

L.A. McKeown

May 01, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

Advertisement

TCTMD’s Biggest News of 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

TCTMD’s Top 10 Most Popular Stories for December 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

FDA Approves Bioresorbable Scaffold for BTK Lesions

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

TCTMD’s Top 10 Most Popular Stories for August 2023

TCTMD’s Top 10 Most Popular Stories for July 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content